ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Vermont » Psychiatry

Top Psychiatry Prescribers in Vermont

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PAUL COTTON M.D.

Psychiatry

5,649

$605K

246
60 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 26%

$107
Average prescription price

Avg: $146

EVELYN GERRETSON MD

Psychiatry

5,512

$977K

256
39 are 65+

4%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$177
Average prescription price

Avg: $146

CATHERINE HICKEY M.D.

Psychiatry

5,237

$978K

243
40 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 26%

$187
Average prescription price

Avg: $146

JUDITH TIETZ M.D.

Psychiatry

4,438

$686K

231
51 are 65+

19%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 26%

$154
Average prescription price

Avg: $146

RICHARD EDELSTEIN MD

Psychiatry

3,457

$616K

162
20 are 65+

18%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 26%

$178
Average prescription price

Avg: $146

KEVIN BUCHANAN M.D.

Psychiatry

3,122

$396K

158
20 are 65+

8%
patients receiving schedule two controlled substances

Avg: 8%

7%
patients receiving schedule three controlled substances

Avg: 3%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$127
Average prescription price

Avg: $146

SANDRA STEINGARD M.D.

Psychiatry

2,934

$357K

152
22 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 26%

$122
Average prescription price

Avg: $146

STEVEN SOBEL MD

Psychiatry

2,711

$360K

163
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$133
Average prescription price

Avg: $146

THEODORE ROBBINS MD

Psychiatry

2,571

$425K

121
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$165
Average prescription price

Avg: $146

CRAIG VANTUINEN MD

Psychiatry

2,425

$444K

97
17 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$183
Average prescription price

Avg: $146

DEREK VINES M.D.

Psychiatry

2,386

$272K

90
0 are 65+

16%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$114
Average prescription price

Avg: $146

JAMES STONE MD

Psychiatry

2,374

$312K

109
24 are 65+

17%
patients receiving schedule two controlled substances

Avg: 8%

19%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 26%

$132
Average prescription price

Avg: $146

JOSEPH LASEK M.D.

Psychiatry

2,342

$233K

103
11 are 65+

24%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$99
Average prescription price

Avg: $146

JENNIFER FAUNTLEROY M.D.

Psychiatry

2,184

$301K

81
0 are 65+

23%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$138
Average prescription price

Avg: $146

KATHLEEN PITTAWAY MD

Psychiatry

2,060

$495K

152
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$240
Average prescription price

Avg: $146

LORRI GOLIN M.D.

Psychiatry

1,897

$266K

93
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$140
Average prescription price

Avg: $146

DAVID ALLAN M.D.

Psychiatry

1,806

$288K

81
12 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$160
Average prescription price

Avg: $146

ADRIAN WEBB MD

Psychiatry

1,705

$392K

89
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 26%

$230
Average prescription price

Avg: $146

FRANCIS KALIBAT MD

Psychiatry

1,687

$145K

63
0 are 65+

17%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 26%

$86
Average prescription price

Avg: $146

WILLIAM GRASS MD

Psychiatry

1,679

$291K

89
20 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 26%

$173
Average prescription price

Avg: $146

KATHLEEN ALLDEN MD

Psychiatry

1,665

$248K

103
18 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$149
Average prescription price

Avg: $146

MARIO HASAJ MD

Psychiatry

1,470

$201K

98
27 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 26%

$137
Average prescription price

Avg: $146

ROBERT DUNCAN M.D.

Psychiatry

1,465

$170K

82
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$116
Average prescription price

Avg: $146

ROBERTA BENNETT M.D.

Psychiatry

1,436

$195K

42
0 are 65+

36%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$136
Average prescription price

Avg: $146

ELLIOT KAUFMAN MD

Psychiatry

1,357

$146K

81
0 are 65+

23%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 26%

$107
Average prescription price

Avg: $146

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank